Certara is the largest and most comprehensive provider of biosimulation (modeling and simulation), strategic pharmacometrics, and regulatory writing consulting services. Our multidisciplinary team works alongside clients to inform key drug development decisions and expedite the processes around achieving regulatory milestones.
Certara combines its industry renowned pharmacometric and regulatory consultants with our vast software portfolio to provide services that focus on specific outcomes, therapeutic areas, regulatory milestones, and specific populations.
United States: 1-888-708-7444 or 1-919-852-4685
France: +33 1 56 95 17 10
Germany: +49 89 45 10 300
United Kingdom: +44 (0) 114 292 2322
India: +91 984 500 6625
Interested in Certara's biosimulation solutions? Want to speak to someone in our sales team? Click on the link below!
Certara has supported over 65 Central Nervous System (CNS) projects for industry clients over the past five years, spanning all phases of clinical development. Our consultants have addressed key issues in trial design, choice of indication, and development strategy for drugs with novel mechanisms of action. We have developed models for assessing the probability a drug in development will be competitive with the standard of care.
Our experience covers a broad range of diseases and conditions within the CNS. Our compilations of public data from the clinical and scientific literature in several CNS disease areas provide a ready context for model-based meta-analysis to assess your compound's performance against competing therapies.
We can help you to develop a modeling and simulation strategy for establishing a comprehensive picture of your CNS drug’s safety and efficacy profile to accelerate clinical development.